Pharmacophylogenomics: genes, evolution and drug targets
Year: 2003
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd1152
Author: David B. Searls
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2059106947
